跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,016 条关于
“ASXL1 mutation”
全部
7,016
临床试验
5,480
药物
33
机构
4
资讯
1,499
去年
SELLAS' SLS009 Shows Promise in ASXL1-Mutated Solid Cancers
去年
ASXL1 Disruption in T Cells Enhances Immunotherapy Response, Improves Tumor Control
去年
SELLAS Life Sciences Receives Positive IDMC Recommendation to Continue Phase 3 REGAL Trial of Galinpepimut-S in AML
10个月前
SELLAS Life Sciences Reports Promising Phase 2 Results for SLS009 in Venetoclax-Resistant AML at ASH 2025
10个月前
SELLAS Life Sciences Secures $31 Million Through Warrant Exercise to Advance Cancer Therapeutics Pipeline
11个月前
SELLAS Life Sciences Announces R&D Day to Showcase Phase 3 AML Trial Results and CDK9 Inhibitor Program
11个月前
SELLAS Life Sciences Reports Promising Preclinical and Phase 2 Data for CDK9 Inhibitor SLS009 Across Multiple Hematologic Malignancies
去年
CD19 CAR-T Cell Therapy Shows Promise in Relapsed t(8;21) AML Despite Short-Term Remission
9个月前
VERONA Trial Shows Mixed Results for Venetoclax-Azacitidine Combination in High-Risk MDS
去年
Smoking Linked to Increased Genetic Mutations and Faster Disease Progression in Myelodysplastic Syndromes
第 1 页,共 150 页
上一页
下一页